Compare, Analyse Aurobindo Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs MYLAN (US) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   MYLAN
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
MYLAN
Dec-18
AUROBINDO PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs8303,495-   
Low Rs5271,924-   
Sales per share (Unadj.) Rs333.91,608.1-  
Earnings per share (Unadj.) Rs40.443.7-  
Cash flow per share (Unadj.) Rs51.8344.8-  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.11,739.7-  
Shares outstanding (eoy) m585.91514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.01.7 120.6%   
Avg P/E ratio x16.862.0 27.1%  
P/CF ratio (eoy) x13.17.9 166.8%  
Price / Book Value ratio x2.91.6 183.8%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,5691,393,882 28.5%   
No. of employees `00017.935.0 51.0%   
Total wages/salary Rs m25,8490-   
Avg. sales/employee Rs Th10,956.923,639.1 46.4%   
Avg. wages/employee Rs Th1,447.70-   
Avg. net profit/employee Rs Th1,324.3641.9 206.3%   
INCOME DATA
Net Sales Rs m195,636827,370 23.6%  
Other income Rs m1,5530-   
Total revenues Rs m197,189827,370 23.8%   
Gross profit Rs m39,519214,093 18.5%  
Depreciation Rs m6,680154,916 4.3%   
Interest Rs m2,62639,794 6.6%   
Profit before tax Rs m31,76719,383 163.9%   
Minority Interest Rs m270-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269-3,084 -235.7%   
Profit after tax Rs m23,64522,467 105.2%  
Gross profit margin %20.225.9 78.1%  
Effective tax rate %22.9-15.9 -143.8%   
Net profit margin %12.12.7 445.1%  
BALANCE SHEET DATA
Current assets Rs m153,645462,003 33.3%   
Current liabilities Rs m120,429336,851 35.8%   
Net working cap to sales %17.015.1 112.2%  
Current ratio x1.31.4 93.0%  
Inventory Days Days13584 161.8%  
Debtors Days Days6493 68.3%  
Net fixed assets Rs m103,909160,496 64.7%   
Share capital Rs m586441 133.0%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,908895,063 15.5%   
Long term debt Rs m1,800966,060 0.2%   
Total assets Rs m264,5442,400,907 11.0%  
Interest coverage x13.11.5 880.7%   
Debt to equity ratio x01.1 1.2%  
Sales to assets ratio x0.70.3 214.6%   
Return on assets %9.92.6 383.0%  
Return on equity %17.02.5 678.2%  
Return on capital %23.83.2 749.7%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,220171,928 9.4%  
From Investments Rs m-28,768-88,868 32.4%  
From Financial Activity Rs m19,191-80,094 -24.0%  
Net Cashflow Rs m6,6561,424 467.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.42 Rs / USD

Compare AUROBINDO PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: STRIDES PHARMA SCIENCE  LUPIN  FULFORD INDIA  NOVARTIS  SUVEN LIFE SCIENCES  



Today's Market

Indian Share Markets Open Higher; JSW Steel & Tata Steel Top Gainers(09:30 am)

Asian share markets edged higher today as investors shrugged off concerns that stocks may have rallied too far too fast in the past year.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


Mar 3, 2021 10:18 AM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS